Login / Signup
Chester Kao
ORCID
Publication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 2
Top Topics
Metastatic Renal Cell Carcinoma
High Dose
Study Protocol
Top Venues
Cancer research communications
The oncologist
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Stephanie L Alden
,
Mir Lim
,
Chester Kao
,
Daniel H Shu
,
Amit G Singal
,
Anne M Noonan
,
Paige Griffith
,
Nilofer S Azad
,
Won Jin Ho
,
Ihab R Kamel
,
Mark Yarchoan
,
David Hsiehchen
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma.
Cancer research communications
3 (7) (2023)
Chester Kao
,
Daniel J George
,
Tian Zhang
An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC).
The oncologist
26 (3) (2020)